Alexander S Krausman, PA-C | |
315 E Main St, Orwell, OH 44076-9590 | |
(440) 437-6222 | |
Not Available |
Full Name | Alexander S Krausman |
---|---|
Gender | Male |
Speciality | Physician Assistant - Medical |
Location | 315 E Main St, Orwell, Ohio |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1750898284 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363AM0700X | Physician Assistant - Medical | 50.005150 (Ohio) | Primary |
Mailing Address | Practice Location Address |
---|---|
Alexander S Krausman, PA-C 2176 Grandview Ave, Cleveland Heights, OH 44106-3133 Ph: (734) 255-8814 | Alexander S Krausman, PA-C 315 E Main St, Orwell, OH 44076-9590 Ph: (440) 437-6222 |
News Archive
Depending on the level of smoking and leisure time exercise, vitamin E supplementation may decrease or increase, or may have no effect, on the risk of pneumonia, according to a study published in Clinical Epidemiology.
Among older adults with subthreshold depression (insufficient levels of depressive symptoms to meet diagnostic criteria), collaborative care compared with usual care resulted in an improvement in depressive symptoms after four months, although it is of uncertain clinical importance, according to a study appearing in the February 21 issue of JAMA.
A systematic review of studies published over the past four decades has confirmed that good doctor-patient communication makes a difference not only in patient satisfaction but in patient outcomes including resolution of chronic headaches, changes in emotional states, lower blood sugar values in diabetics, improved blood pressure readings in hypertensives, and other important health indicators.
Organogenesis, Inc. announced today that it has filed a Premarket Approval Application (PMA) with the U.S. Food and Drug Administration (FDA) for its CelTx(TM), a living cellular construct for oral soft tissue regeneration. If approved, CelTx will be the first, living cell-based technology that is FDA-approved for use in the dental market.
Investigators from an international consortium of research institutes, including the Johns Hopkins Bloomberg School of Public Health, have identified compounds that mimic the effects of a low calorie diet without changing the amount of essential nutrients.
› Verified 3 days ago